A Study on Various Types of Presentations of Paediatric Tuberculosis and Response to Fixed Dose Combination (FDC). Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020
Late Breaking Abstract - A New study of the Prevalence of COPD in Spain: EPISCAN II Source: International Congress 2019 – COPD: epidemiology and spirometry Year: 2019
Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019
Introduction to T he E pidemiology and N atural History of Asthma: O utcomes and Treatment R egimens (TENOR) study Source: Eur Respir J 2002; 20: Suppl. 38, 426s Year: 2002
Evaluation of optimal regimens for treatment of rifampicin resistant-tuberculosis: Multicenter, randomized controlled study in China Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods Source: Eur Respir J 2004; 24: 406-412 Year: 2004
Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019 Year: 2020
Safety, Tolerability (S&T) and Pharmacokinetics (PK) of Single and Repeat Inhaled Doses of Phosphoinositide-3-Kinase Delta Inhibitor (PI3Kd) GSK2269557, Delivered via the ELLIPTATM Device to Healthy Subjects in a Phase I Trial, Including Charcoal Block. Source: International Congress 2017 – Pulmonary drug and devices delivery Year: 2017
Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Preventing MDRTB in Europe: Drug sensitivities received after the initial phase of treatment Source: International Congress 2016 – Drug-resistant tuberculosis and experiences with delamanid and bedaquiline Year: 2016
Risk of Haemophilus Influenzae Infection in Patients with Chronic Obstructive Pulmonary Disease Using Inhaled Corticosteroids: A Cohort Study of 23,789 Outpatients. Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021
LATE-BREAKING ABSTRACT: LAVOLTA I and II: Results of 2 phase III studies to assess the efficacy and safety of lebrikizumab in patients with uncontrolled asthma Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016
Randomized Phase III Trial Assessing Regional Lung Function for Lung Transplant by Hyperpolarized 129Xenon Gas MRI Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020
A cohort evaluation of WHO class II and IV TB patients treated at the National Institute of Respiratory Diseases (INER) Source: Eur Respir J 2001; 18: Suppl. 33, 474s Year: 2001
FENO Guided Therapy in Asthma: A Non-inferiority Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Analysis of comorbidities and treatment patterns by GOLD 2013 criteria: Pooled data from Phase III aclidinium bromide studies Source: International Congress 2014 – Asthma and COPD management Year: 2014
The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers Source: Eur Respir J, 52 (4) 1801665; 10.1183/13993003.01665-2018 Year: 2018
Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort. Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019
Treatment Outcomes of Tuberculosis among New Smear Positive and Retreatment Cases: Retrospective Study in Two Egyptian Governorates Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019